• Machine Learning-Guided LNPs for mRNA Delivery to Microglia

  2026-05-11

  This study demonstrates a machine learning-assisted approach to optimize immunomodulatory lipid nanoparticles (LNPs) for targeted mRNA delivery to hyperactivated microglia. By integrating supervised ML models with systematic formulation and phenotypic screening, the research identifies carrier designs that can effectively reprogram inflammatory microglia, offering new strategies for neuroinflammatory disorder therapies.

• Early Pheromone Sensing Drives Neurodegeneration in C. elega

  2026-05-11

  Peng et al. (2023) demonstrate that early exposure to specific pheromones in C. elegans remodels neurodevelopment and accelerates adult neurodegeneration by integrating multiple chemosensory pathways. This work clarifies how environmental chemical cues can shape lifelong neuronal health, offering mechanistic insight for neurodegenerative disease modeling.

• Alternariol in Mycotoxin Research: Protocols and Troubleshoo

  2026-05-10

  Alternariol (AOH) is central to modeling mycotoxin-induced liver fibrosis and apoptosis pathways, offering unique leverage in cytochrome P450 enzyme assays and omics-based toxicity research. This article bridges the latest mechanistic findings with actionable workflows and troubleshooting insights for advanced fungal toxin studies.

• Alternariol Induces Hepatic Stellate Transdifferentiation an

  2026-05-09

  This study elucidates how Alternariol (AOH), a key Alternaria mycotoxin, triggers hepatic stellate cell activation and drives liver fibrosis through NF-κB, ferroptosis, and autophagy signaling. Integrating lncRNA-mRNA omics and a novel enzymatic detoxification approach, the research advances understanding of mycotoxin-driven hepatotoxicity and informs future risk management strategies.

• UBE2F-SAG Axis Drives RHEB Neddylation and mTORC1 in Liver C

  2026-05-08

  This study establishes RHEB as a neddylation substrate of the UBE2F-SAG axis, showing that this modification amplifies mTORC1 activity and worsens liver tumorigenesis. The findings suggest that targeting UBE2F-mediated neddylation could offer new therapeutic strategies for hepatocellular carcinoma and steatosis.

• Gallein and the Future of GPCR Research: Mechanisms to Impac

  2026-05-08

  This article provides advanced translational researchers with mechanistic insights and strategic guidance on leveraging Gallein—a selective G protein βγ subunit inhibitor—for dissecting and modulating GPCR signaling. Bridging foundational and cutting-edge findings, including new paradigms in insulin-independent glucose uptake, the discussion highlights protocol recommendations, competitive positioning, and actionable translational strategies, with a forward-looking outlook on cardiovascular, immuno-oncology, and metabolic disease research.

• Machine Learning Advances Lipid Nanoparticle mRNA Vaccine De

  2026-05-07

  This study presents a machine learning-driven approach for predicting optimal lipid nanoparticle (LNP) formulations for mRNA vaccine delivery, focusing on the role of ionizable cationic liposomes such as Dlin-MC3-DMA. Experimental validation confirms the algorithm's predictive power, marking a significant step towards data-driven LNP optimization and accelerating nucleic acid therapeutic development.

• Lactobacillus gasseri Modulates Colitis via NR1I3–E-cadherin

  2026-05-07

  This study uncovers how Lactobacillus gasseri ATCC33323 alleviates DSS-induced colitis in mice by preserving the intestinal mucosal barrier through NR1I3-mediated upregulation of E-cadherin. The mechanistic findings advance our understanding of probiotic action in inflammatory bowel disease and offer translational insights for future therapeutic strategies.

• Recombinant Human Oncostatin M: Cytokine Crossroads in Diffe

  2026-05-06

  Explore the advanced roles of Recombinant Human Oncostatin M in orchestrating cellular differentiation and X-chromosome inactivation. This article integrates new mechanistic insights and practical assay guidance, providing a unique perspective not covered by standard protocol or workflow guides.

• CH 223191: Precision AhR Antagonism for Toxicology & Regener

  2026-05-06

  CH 223191 stands out as a potent aryl hydrocarbon receptor antagonist for researchers aiming to dissect AhR signaling in environmental toxicology and regenerative medicine. This article unpacks validated experimental workflows, troubleshooting insights, and translational applications—bridging the latest mechanistic findings with actionable bench protocols.

• Tigecycline: Glycylcycline Antibiotic for Multidrug-Resistan

  2026-05-05

  Tigecycline from APExBIO offers robust activity against multidrug-resistant bacteria, enabling advanced experimental workflows in resistance research. This article details stepwise protocols, troubleshooting strategies, and the translational significance of recent findings in carbapenem-resistant Enterobacter cloacae for optimizing antimicrobial assays.

• Sisomicin vs. Tobramycin: In Vitro Activity Against Clinical

  2026-05-05

  The referenced study systematically compared the in vitro activity of the aminoglycoside antibiotic sisomicin to gentamicin and tobramycin across a broad panel of clinical Gram-negative and Gram-positive isolates. The findings highlight nuanced differences in efficacy and resistance patterns, informing both antibiotic selection and resistance research strategies.

• IWP-2: Wnt Production Inhibitor for Cancer & Pathway Assays

  2026-05-04

  IWP-2, a potent Wnt production inhibitor from APExBIO, empowers researchers to dissect the Wnt/β-catenin pathway with high specificity and reproducibility. This article delivers practical protocols, troubleshooting tips, and translational insights for leveraging IWP-2 in advanced cancer research and functional genomics.

• D-Lin-MC3-DMA: Ionizable Cationic Liposome for RNA Therapeut

  2026-05-04

  D-Lin-MC3-DMA is a benchmark ionizable cationic liposome lipid, enabling efficient siRNA and mRNA delivery via lipid nanoparticles. Its potency for hepatic gene silencing and endosomal escape is well-documented, with orders-of-magnitude increased efficacy over earlier lipids. This article details mechanistic insight, evidence, and integration protocols for RNA delivery.

• Genistein in Action: Protocols and Troubleshooting for Cance

  2026-05-03

  Harnessing the selective tyrosine kinase inhibition of Genistein empowers researchers to dissect oncogenic signaling and cytoskeleton-driven autophagy with precision. This guide delivers practical protocols, troubleshooting insights, and strategic advantages for maximizing Genistein’s impact in cancer biology workflows.

14550 records 1/970 page Next 12345 下5页 Last page